Crowdonomics
WatchlistPortfolio
All companies
Aqua Research logo

Aqua Research

Operating

Aqua Research, Inc.

Industrial & Manufacturing · Founded 2011

Visit website

Innovative, affordable, and sustainable disinfection technology

Post-money valuation ⓘ
$7.1M
As of Apr 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$36,233
Across 1 round since 2023
Latest share price
$1.63
Reg CF · Common Stock · Feb 2023 offering price

Financials

FY2020–FY2025 (no data for FY2022, FY2023) · from SEC filings · hover any figure for its source
$1.2M
$53K
2020
$665K
−$75K
2021
2022no data
2023no data
$1.4M
−$408K
2024
$1.7M
$344K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
FY2024
FY2025
Income statement
Revenue
$1,175,727
$665,355
$1,397,484
$1,661,782
Cost of goods sold
$550,940
$351,215
$98,032
$38,120
Gross margin
53%
47%
93%
98%
Net income
$52,755
-$75,010
-$408,407
$344,208
Taxes paid
$0
$0
$5,491
-$344
Balance sheet
Cash
$98,533
$108,906
$145,608
$188,771
Accounts receivable
$0
$11,792
$17,831
$29,332
Total assets
$253,788
$447,877
$1,001,408
$1,110,555
Short-term debt
$523,887
$630,486
$464,440
$267,468
Long-term debt
$0
$54,125
$1,004,740
$1,075,394
Total liabilities
$523,887
$684,611
$1,469,179
$1,342,862
Other
Headcount
—
5
—
7

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$7.1M
pre-money
Reg CF · Common · Feb 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Feb 2023Closedvia Netcapital
Raised $36.2K / $1.2MPost-money $7.1M

Team

2 people
Gene Rabent
Principal Executive Officer
Rodney Herrington
Principal Financial Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Possibly delinquent

Filed 1 of 4 annual reports (FY2022–FY2025)

Missing: 2022, 2023, 2024

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARSep 1, 20260001962609-26-000003
    EDGAR
  • Form C-USep 1, 20230001669191-23-000829
    EDGAR
  • Form C/AMar 9, 20230001669191-23-000239
    EDGAR
  • Form CFeb 3, 20230001669191-23-000114
    EDGAR
Source: ManualCIK 0001962609Share price $1.63

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.